Sanara MedTech Revenue and Competitors

Dallas, TX USA

Location

$41.6M

Total Funding

Estimated Revenue & Valuation

  • Sanara MedTech's estimated annual revenue is currently $24.6M per year.(i)
  • Sanara MedTech's estimated revenue per employee is $270,000
  • Sanara MedTech's total funding is $41.6M.

Employee Data

  • Sanara MedTech has 91 Employees.(i)
  • Sanara MedTech grew their employee count by 28% last year.

Sanara MedTech's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Staff to the CEOReveal Email/Phone
3
VP, Medical Sciences and TechnologyReveal Email/Phone
4
VP, ClinicalReveal Email/Phone
5
Director, Medical Education, ContentReveal Email/Phone
6
Marketing DirectorReveal Email/Phone
7
Director Financial ReportingReveal Email/Phone
8
Chief Financial OfficerReveal Email/Phone
9
Director Manufacturing and CommercializationReveal Email/Phone
10
Marketing DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8M3716%N/AN/A
#2
$12.6M5230%N/AN/A
#3
$15.1M6217%N/AN/A
#4
$48.4M16315%N/AN/A
#5
$12.6M526%N/AN/A
#6
$12.6M5241%N/AN/A
#7
$4.7M2519%N/AN/A
#8
$14.3M5944%N/AN/A
#9
$10.8M500%N/AN/A
#10
$8.6M408%N/AN/A
Add Company

What Is Sanara MedTech?

With our focus on improving patient outcomes with evidence-based healing solutions, Sanara MedTech Inc., formerly named WNDM Medical Inc., develops, markets and distributes biotechnology products to physicians, hospitals, clinics and all post-acute care settings. We are constantly seeking long-term strategic partnerships with a focus on products that produce efficacious outcomes at a lower overall cost. Our primary products are sold in the North American advanced wound care and surgical tissue repair markets. Sanara MedTech sells and distributes CellerateRX®/CRXα® Surgical Activated Collagen® Adjuvant and HemaQuell® Resorbable Bone Hemostat to the surgical market and BIAKŌS Antimicrobial Skin and Wound Cleanser™, HYCOL™ Hydrolyzed Collagen, and PULSAR II™ Advanced Wound Irrigation System (AWI™) to the wound care marke

keywords:N/A

$41.6M

Total Funding

91

Number of Employees

$24.6M

Revenue (est)

28%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Sanara MedTech News

2022-04-19 - Sanara MedTech Inc. (NASDAQ:SMTI): Is Breakeven Near?

According to some industry analysts covering Sanara MedTech, breakeven is near. They anticipate the company to incur a final loss in 2022,...

2022-04-06 - Sanara MedTech Inc. Announces Entry into Merger ...

Sanara MedTech Inc. Announces Entry into Merger Agreement to Acquire Precision Healing Inc. · FORT WORTH, TX, April 04, 2022 (GLOBE NEWSWIRE) --...

2022-03-30 - Sanara MedTech Inc. Announces Fourth Quarter and Full ...

Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a provider...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16.4M9147%N/A
#2
$22.8M9134%N/A
#3
$1.7M9277%N/A
#4
$20.9M92-4%N/A
#5
$0M9212%N/A